InflaRx NV (IFRX)
1.45
+0.05
(+3.57%)
USD |
NASDAQ |
May 16, 16:00
1.44
-0.01
(-0.69%)
After-Hours: 20:00
InflaRx Cash from Investing (TTM): 13.96M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 13.96M |
December 31, 2023 | -19.16M |
September 30, 2023 | -19.61M |
June 30, 2023 | -23.37M |
March 31, 2023 | -13.15M |
December 31, 2022 | 20.42M |
September 30, 2022 | -22.12M |
June 30, 2022 | -19.67M |
March 31, 2022 | 0.2751M |
December 31, 2021 | -30.70M |
September 30, 2021 | -0.6665M |
June 30, 2021 | 4.410M |
March 31, 2021 | 26.13M |
Date | Value |
---|---|
December 31, 2020 | 24.40M |
September 30, 2020 | 60.10M |
June 30, 2020 | 25.85M |
March 31, 2020 | 20.07M |
December 31, 2019 | 22.77M |
September 30, 2019 | 1.972M |
June 30, 2019 | -88.16M |
March 31, 2019 | -117.57M |
December 31, 2018 | -117.43M |
September 30, 2018 | -122.63M |
June 30, 2018 | -10.15M |
March 31, 2018 | -0.3199M |
December 31, 2017 | -0.1892M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-88.16M
Minimum
Jun 2019
60.10M
Maximum
Sep 2020
-0.8134M
Average
1.124M
Median
Cash from Investing (TTM) Benchmarks
Affimed NV | -39.04M |
MorphoSys AG | -- |
BioNTech SE | -9.242B |
Immatics NV | -292.65M |
CureVac NV | -59.76M |